Tumor cells in chronic lymphocytic leukemia (CLL) are more prone to apoptosis when cultured ex vivo, because they lack prosurvival signals furnished in vivo via B-cell receptor (BCR)-dependent and -independent pathways. This study compared the susceptibility of unmutated (UM) and mutated (M) CLL B cells to spontaneous apoptosis and prosurvival signals. UM CLL B cells showed a significantly higher rate of spontaneous apoptosis than M CLL B cells. Nuclear factor-kB (NF-kB) was rapidly inactivated, and B-cell leukemia/lymphoma 2 (Bcl-2) expression progressively down-regulated in the UM CLL B cells. CD40-Ligand, interleukin-4 and stromal cells significantly improved their viability and partially recovered Bcl-2, but not NF-kB expression. Peripheral blood mononuclear cells also offered protection of UM CLL B cells, and recovered both NF-kB and Bcl-2 expression. T cells, rather than nurse-like cells, were responsible for protecting UM CLL B cells by means of cell-to-cell contact and soluble factors. Despite their more aggressive features, UM CLL B cells are more susceptible to spontaneous apoptosis and depend from environmental prosurvival signals. This vulnerability of UM CLL B cells can be exploited as a selective target of therapeutic interventions.
Introduction
Chronic lymphocytic leukemia (CLL) is a malignancy characterized by the accumulation of monoclonal CD5 þ B lymphocytes. CLL B cells typically undergo spontaneous apoptosis under conditions that support the growth of human B-cell lines in vitro. Therefore, the malignant behavior of CLL B cells cannot be only ascribed exclusively to their intrinsic features, but also to factors originating from the surrounding microenvironment. Two main factors are critical for the survival of CLL B cells: (1) B-cell receptor (BCR)-dependent antigen (Ag) stimulation; (2) BCR-independent interactions with the neighboring nonneoplastic environment. 1 The immunoglobulin heavy-chain variable region (IGHV) mutational status defines two subtypes of CLL. Patients carrying mutated (M) IGHV follow a more indolent course than those with unmutated (UM) IGHV, who instead suffer from a more aggressive disease. 2, 3 It is already known that the IGHV mutational status endows CLL B cells with a different capacity to signal through the BCR, 4 but it is currently unknown whether UM and M CLL B cells have a different susceptibility to spontaneous apoptosis, and to what extent they depend on environmental signals for survival.
CLL B cells can be rescued from spontaneous apoptosis when co-cultured with bone marrow-derived stromal cells (BMSC) [5] [6] [7] [8] [9] or nurse-like cells (NLC), [10] [11] [12] generated from the peripheral blood (PB) of CLL patients. The same protection is granted when CLL B cells are co-cultured with activated autologous T cells or T-cell derived cytokines (CK) and T-cell-related molecules, such as interleukin (IL)-4 and soluble CD40 ligand (CD40 L). 9, 13 BCR stimulation and environmental interactions activate the canonical and alternative Nuclear factor-kB (NF-kB) signaling pathways culminating in nuclear translocation of active dimers (that is, RelA:p50 and c-Rel:p50 for the canonical pathway; RelB:p52 for the alternative pathway). [13] [14] [15] Once in the nucleus, NF-kB enhances cell survival by inducing the production of antiapoptotic proteins, such as B-cell leukemia/lymphoma 2 (Bcl-2) and Bcl-2 family proteins. [16] [17] [18] It was recently reported that CLL B cells have a heterogeneous ability to activate NF-kB in response to BCR stimulation, and that the magnitude of NF-kB induction is associated with the suppression of in vitro apoptosis. 16 However, it is unknown whether NF-kB activation is associated with the IGHV mutational status.
The aim of this study was threefold: (1) to determine the intrinsic susceptibility of purified M and UM CLL B cells to spontaneous apoptosis; (2) to investigate the ability of environmental signals to rescue M and UM CLL B cells from apoptosis; (3) to correlate the susceptibility to spontaneous apoptosis and the recovered cell survival, eventually induced by environmental signals, with NF-kB activation and Bcl-2 expression. Our results indicate that UM CLL B cells are more prone to spontaneous apoptosis than M CLL B cells, because they are much more dependent on environmental prosurvival signals. This vulnerability can be converted into therapeutic opportunities selectively targeting UM CLL B cells.
Materials and methods

Patients
Seventy-one untreated CLL patients, 27 females and 44 males, median age of 60 years (range, 33-82 years), were included in this study. Patient demographics and clinical characteristics of the CLL cohort are reported in Supplementary Table 1. CLL was defined by clinical examination, PB cell count and immunophenotypic criteria. Tumor IGHV rearrangements were amplified starting from genomic DNA as described elsewhere. 19 Sequences with deviation o2% or X2% from the germline IGHV sequence were considered UM or M, as previously reported. 19 Cell purification and cell lines Samples were collected after informed consent and approval by the local Institutional Review Boards. Peripheral blood mononuclear cells (PBMC) from M (M PBMC) and UM (UM PBMC) patients were isolated by density gradient centrifugation (FicollHistopaque, PAA Laboratories GmbH, Linz, Austria). PBMC were used without further manipulation when they contained more than 91% of CLL B cells (CD19 þ /CD5 þ ), whereas PBMC with less than 91% of CLL B cells were further processed, and CLL B cells were purified by negative selection using a Magnetic Bead-Activated Cell Sorting (MACS), with a B Cell Isolation Kit II (Miltenyi Biotec, Bologna, Italy).
In selected experiments, the M2-10B4 murine stromal cell line (ATCC, cat. num. CRL-1972) or BMSC derived from two multiple myeloma (MM) and two CLL patients were used. BMSC were generated by culturing bone marrow cell suspensions in 24-well plates (2 Â 10 6 cells/well) in Dulbecco's Modified Eagle's Medium (DMEM) (PAA Laboratories GmbH), containing 10% heat-inactivated fetal calf serum (FCS) (Euroclone, Milano, Italy), 2 mM L-glutamine, 100 U/ml penicillin and 100 mg/ml streptomycin. After 4-days incubation multiple foci of adherent spindle-like cells appeared, and the non-adherent cells were washed away. Culture medium was replenished every 3 days and BMSC were split when they reached a confluent status.
NLC were generated as previously described. 10, 11 Briefly, PBMC from M and UM patients were dispensed into 6-well flat-bottomed plates (15 Â 10 6 cells/well). At different intervals, the non-adherent cells were harvested and evaluated for CD19 þ /CD5 þ cell viability. Concurrently, outgrowth of adherent NLC was assessed by phase-contrast microscopy (stromal cell-like appearance), implemented by FACS analysis (high FSC and SSC values).
In selected experiments, both CLL B cells and autologous peripheral blood T cells were purified. First, monocytes were removed using CD14 MicroBeads and MS columns (Miltenyi Biotec). T cells were purified by negative selection using a Pan T Cell Isolation Kit II, according to the manufacturer's instructions (Miltenyi Biotec).
Culture and co-culture conditions PBMC and CLL B cells were cultured in 24-well plates (Costar, Cambridge, MA, USA) (10 6 cells/well) at 37 1C in a 5% CO 2 humidified incubator. The standard culture medium was RPMI 1640 (Euroclone) supplemented with 10% FCS, 2 mM L-glutamine, 100 U/ml penicillin and 100 mg/ml streptomycin. Culture conditions included: medium alone, IL-4 (Pepro-Tech EC Ltd, London, UK) at a final concentration of 2 ng/ml, and/or CD40 L plus enhancer (Alexis Biochemicals, Vinci, Italy) at a final concentration of 100 ng/ml.
For co-culture experiments, murine or human stromal cells were harvested through Trypsin-EDTA (Sigma-Aldrich, Milan, Italy) digestion, and plated in 24-well plates (50 Â 10 3 cells per well) in complete culture medium. CLL B cells (10 6 cells per well) were added to the culture the following day.
CLL B cells and autologous T cells, both purified by negative selection, were co-cultured in 24-well plates, either alone or in the same reciprocal proportion detected by flow-cytometry in unfractionated PBMC. To explore the relative contribution of cell-to-cell contact vs soluble factors in mediating apoptosis protection, micropore membranes were used to separate CLL B cells and T cells (24-well Millicell Hanging Cell Culture Inserts, 0.4 mm pore size, Millipore, Milano, Italy). Apoptosis, Bcl-2 expression and NF-kB nuclear translocation were evaluated on day 7.
To examine the ability of CK to induce nuclear translocation of NF-kB, M and UM CLL B cells were cultured in 24-well plates (2 Â 10 6 cells/well), with tumor necrosis factor-alpha (TNF-a) (5 pg/ml, 100 pg/ml, 1 ng/ml; Pepro-Tech), plateletderived growth factor (PDGF-BB) (5 pg/ml, 100 pg/ml, 1 ng/ml; ImmunoTools, Friesoythe, Germany) and IL-8 (300 pg/ml, 1 ng/ml, 10 ng/ml; ImmunoTools). 
Quantification of apoptotic and viable cells
Intracellular Bcl-2 detection
Intracellular detection of Bcl-2 was performed on PBMC and CLL B cells as previously reported, 20 using saponin (SigmaAldrich) as the permeabilizing agent and a FITC-conjugated anti-Bcl-2 mAb (Dako SpA).
NF-kB detection by EMSA
The activation of NF-kB was measured in PBMC, in CLL B cells and in purified T cells, by electrophoretic mobility shift assay (EMSA), as previously described. 21 RelA and RelB NF-kB DNA binding detection Ten mg of nuclear extracts from CLL B cells were assayed for RelA and RelB activity with the TransAM Flexi NF-kB Family assay kit, according to the manufacturer's instructions (Active Motif, Carlsbad, CA, USA). Samples were allowed to bind to the biotinylated probe of the kit, containing a NF-kB consensus site. The NF-kB subunits were subsequently detected using a RelA and RelB-specific antibody (Active Motif) and a horseradish peroxidase-conjugated secondary antibody. The optical density at 450 nm (OD450) was read on a Packard EL340 microplate reader (Bio-Tek Instruments, Winooski, VT, USA). A blank was prepared for each experiment in the absence of cells, and its absorbance was subtracted from that obtained in the presence of the sample. Results were expressed as U absorbance/mg nuclear proteins for each sample.
CK and chemokines (CC) quantification
CK and CC released in culture supernatants were measured using a multiplex suspension array system, containing dyed microspheres conjugated with mAbs specific for target CK or CC (Bio-Rad Laboratories S.r.l., Milano, Italy), as previously described. 22 The panel included IL-1, IL-1ra, IL-2, IL-4, IL-5, IL-6, IL-7, IL-8, IL-9, IL-10, IL-12 (p70), IL-13, IL-15, IL-17, basic fibroblast growth factor (bFGF), eotaxin, granulocyte colony-stimulating factor (G-CSF), granulocyte-macrophage colony-stimulating factor (GM-CSF), interferon-gamma (IFN-g), interferon-inducible protein-10 (IP-10), monocyte chemotactic protein-1 (MCP-1), macrophage inflammatory protein 1 alpha (MIP-1a), macrophage inflammatory protein 1 beta (MIP-1b), PDGF-BB, RANTES, TNF-a, vascular endothelial growth factor (VEGF). Results were analyzed using the Bio-Plex array reader and the Bio-Plex Manager software (Bio-Rad Laboratories S.r.l.).
Statistical analysis
Results are expressed as mean ± s.e.m. The datasets derived in this study were evaluated with a normality test. Where the data were deemed to be Gaussian or approximately Gaussian, the datasets were compared using parametric assays (equal variance or paired Student's t-test); in all other cases, a Mann-Whitney test was used. A P-value of 0.05 or less was considered as a significant difference. All statistical analyzes were performed using SigmaStat 3.5 software (Systat Software Inc., Chicago, IL, USA).
Results
UM CLL B cells have increased susceptibility to spontaneous apoptosis correlating with Bcl-2 downregulation and NF-kB inactivation
UM and M CLL B cells (491% pure as described above) were cultured in standard medium and evaluated for spontaneous apoptosis after 1, 3, 5 and 7 days of culture. Both M and UM CLL B cells underwent apoptosis throughout the culture period. However, the UM CLL B cells showed a significantly higher degree of apoptosis. The difference in M and UM CLL B cells viability was already evident at day 1 and peaked after 7 days of culture (P ¼ 0.0039 and P ¼ 0.03, respectively) ( Figure 1a and Supplementary Figure 1A) . We also evaluated whether in vitro apoptosis might be linked with other prognostic parameters. Interestingly, we did not observe any difference in spontaneous apoptosis based on CD38 and ZAP70 expression, stage of disease and genomic aberrations. Higher in vitro viability of M CLL B cells was not because of a higher proliferation rate. Indeed, both M and UM CLL B cells behaved as quiescent cells and displayed very low levels of [3H]TdR incorporation (Supplementary Figure 1B) .
Next, we investigated the role of NF-kB and Bcl-2. In both M and UM CLL B cells, high basal levels of Bcl-2 expression ( Figure 1b ) and NF-kB activity ( Figure 1c In the same patients NF-kB activity was also evaluated by quantitative analysis of RelA and RelB subunits. Results from this analysis showed that on day 7 RelA and RelB were consistently reduced in nuclear extracts of UM CLL B cells and that RelB levels were significantly lower in UM than in M CLL B cells þ cells was significantly higher for M than for UM CLL B cells on D7 (*P ¼ 0.007). (c) NF-kB DNA binding activity. On D7, NF-kB expression was still detectable in nuclear extracts of CLL B cells from 3 M patients (UPN, unique patient number), whereas it was completely down-modulated in nuclear extracts of CLL B cells from 3 UM patients (top panels). In the same samples, NF-kB activity was also evaluated by a quantitative subunit-specific ELISA assay (bottom panels). On D7 RelB levels were significantly lower in UM than in M CLL B cells (Po0.001). (d) Time-dependent NF-kB modulation in M and UM CLL B cells. UPN-2 (M) and UPN-7 (UM) were evaluated by EMSA (top panels) and by subunit-specific ELISA assay (bottom panels). As shown, inactivation of NF-kB in UM CLL B cells was already evident at D1 of culture.
(Po0.001) (Figure 1c, lower panels) . Of note, NF-kB loss in UM CLL B cells was an early event already occurring after 24 h of culture (Figure 1d) .
These results indicate that the higher apoptotic rate of UM CLL B cells is associated to rapid inactivation of the NF-kB signaling pathway and to progressive downregulation of Bcl-2 expression.
Spontaneous apoptosis of UM CLL B cells is prevented by environmental signals leading to the recovery of Bcl-2, but not of NF-kB expression
To study the effect of environmental signals on spontaneous apoptosis, UM and M CLL B cells were cultured with IL-4 and CD40 L, alone and in combination, with the murine stromal cell line M2-10B4 and with human BMSC derived from CLL and MM patients. As expected, viability of the UM CLL B cells cultured for 7 days in standard medium was significantly lower than that of M CLL B cells (Po0.001) (Figure 2a) . Upon exposure to all tested survival stimuli, UM CLL B cells displayed a significant increase in viability (constantly Pp0.003) (Figure 2a) , which was associated to a significant increase in the percentage of (Figure 2b ). Representative FACS analysis of Bcl-2 expression in UM CLL B cells, in the presence or absence of environmental signals, are reported in Figure 2c . Of note, viability and Bcl-2 expression of M CLL B cells were significantly increased only by exposure to M2-10B4 cells and BMSC (constantly Pp0.019 and Pp0.003, respectively), whereas they were unaffected by IL-4 and CD40 L (Figures 2a and b) . The protective effect exerted by IL-4, CD40 L and stromal cells on UM CLL B cells was totally independent from the recovery of NF-kB expression (Supplementary Figure 2) . As shown by quantitative ELISA assay (Figure 2d ), RelA and RelB levels on day 7 were consistently reduced in nuclear extracts of UM CLL B cells (Po0.001), and none of the stimuli was capable to restore them. Of note, the higher viability of M CLL B cells was associated with the retention of RelA and RelB levels independently of the presence or absence of IL-4, CD40 L and murine stromal cells. Similarly, the CLL and MM-derived stromal cells had no effect on NF-kB expression in M and UM CLL B cells (Supplementary Figure 2) . Spontaneous apoptosis of UM CLL B cells is prevented by PBMC leading to the recovery of both Bcl-2 and NF-kB expression
We next examined whether other cellular components could reverse the susceptibility of UM CLL B cells to apoptosis. To this aim, leukemic cells were cultured either purified (M and UM CLL B cells) or as a component of unfractionated autologous PBMC (M or UM PBMC), and evaluated for spontaneous cell death at different intervals.
Autologous PBMC exerted a protective effect on the survival of leukemic cells. Indeed, after 7 days of culture, cell viability was significantly higher in UM PBMC than in UM CLL B cells (P ¼ 0.009) (Figures 3a and b) . The reduced apoptosis detected in UM PBMC was accompanied by a significant increase in the absolute number of viable and Bcl-2 þ leukemic cells at days 5 and 7 of culture (Pp0.014 and Pp0.012, respectively) ( Figure 3c ). In contrast, cell viability and Bcl-2 expression were very similar in M PBMC and purified M CLL B cells (Supplementary Figure 3) .
We next examined whether the anti-apoptotic effect exerted by UM PBMC was associated to a positive regulation of NF-kB activity. After 7 days of culture, NF-kB was expressed by UM PBMC, whereas it was totally undetectable in nuclear extracts of autologous purified UM CLL B cells. To demonstrate that NF-kB expression was imputable to UM CLL B cells and not to other PBMC cell subsets, the former were isolated on day 7 and NF-kB expression was determined immediately after their isolation (Figure 3d) .
Altogether, these results indicate the presence of a prosurvival cell component in the PB of UM patients, which is capable of rescuing UM CLL B cells from apoptosis by positively regulating NF-kB activity and Bcl-2 expression.
Defective NLC generation from UM PBMC
In the next series of experiments, we investigated the role of NLC in rescuing UM CLL B cells from apoptosis. We initially evaluated whether M and UM PBMC generated NLC with the same efficiency. Unexpectedly, the former generated significantly higher numbers of NLC than UM PBMC. Pooled data and kinetics of NLC generation are shown in Figure 4a , whereas representative FACS analysis of NLC generation from M PBMC and UM PBMC on day 7 are shown in Figure 4b . On day 7 of culture, PBMC from M patients formed a monolayer of large, round cells, which were surrounded by clusters of smaller leukemic cells. On day 14, the cells had increased in size and formed a layer of fibroblast-like cells (Figure 4c , upper panels). In contrast, NLC generation was significantly impaired in PBMC of UM patients (Figure 4c , lower panels). Despite the lack of generation of NLC, the proportion of viable CLL B cells in the non-adherent fraction on days 7 and 14 was very similar in both the M and UM samples (Figure 4d ). In the same way, we observed no significant difference in the mean number of viable Figure 4) . These data indicate that the protective effect exerted by PBMC on UM CLL B cells is independent of NLC.
Autologous T cells play an essential role in supporting UM CLL B cell survival by inducing the expression of Bcl-2 and NF-kB
Next we explored whether T cells were the PBMC cell population responsible for the NF-kB-associated prosurvival effect on UM CLL B cells. To this end, M and UM CLL B cells were cultured either alone or in the presence of purified autologous T cells. Co-culture experiments were performed according to the B cell:T cell ratio detected in the respective PBMC, in order to reproduce the same conditions occurring in vivo. As expected, there was a significant reduction in the proportion of viable cells when UM CLL B cells were cultured for 7 days in medium alone (P ¼ 0.003). Viability was significantly increased in CLL B cell/T cell co-cultures compared with CLL B cells cultured alone (P ¼ 0.02) (Figure 5a, left) .
Freshly isolated UM CLL B cells displayed high basal levels of NF-kB (Figure 5b , left) and Bcl-2 (Figure 5c , left) expression. As expected, after 7 days of culture in medium alone, UM CLL B cells had completely lost their NF-kB activity, which, in contrast, was restored in CLL B cell/T cell co-cultures. ELISAbased quantitative analysis showed that both RelA and RelB levels were reduced in nuclear extracts from purified UM CLL B cells on day 7, whereas they were significantly upregulated by the presence of autologous T cells (P ¼ 0.002 and Po0.001, respectively) (Supplementary Figure 5) . Titration experiments, performed by co-culturing UM CLL B cells with increasing numbers of autologous T cells, showed a dose-dependent modulation of NF-kB activity (Supplementary Figure 6) .
The NF-kB mediated anti-apoptotic effect exerted by T cells was not completely dependent on Bcl-2 modulation. Indeed, in UM CLL B cell/T cell co-cultures Bcl-2 expression was only partially restored (Figure 5c, left) . As expected, viability, NF-kB activity and Bcl-2 expression of M CLL B cells did not decrease during culture and were not dependent on the presence of autologous T cells ( Figure 5 , right panels).
Both cell-to-cell contact and soluble factors protect UM CLL B cells from apoptosis
To investigate whether the protective effect exerted by T cells on CLL B cells was mediated by cell-to-cell contact or by soluble factors, we performed the last series of experiments in trans-well (TW) plates. The viability of the UM CLL B cells was significantly increased in the presence of autologous T cells, whether in cellto-cell contact or in TW (P ¼ 0.039 and P ¼ 0.02, respectively). The difference between cell-to-cell contact and TW co-culture was not significant (Figure 6a and Supplementary Figure 7A) . The anti-apoptotic effect exerted by T cells on autologous UM CLL B cells was associated to a positive regulation of NF-kB activity (Figure 6b ), but only partially depended on Bcl-2 modulation (Supplementary Figure 7B) . Co-culture's supernatants were examined for the secretion of 27 CKs and CCs using a multiplex system. The entire set of data is reported in Supplementary Table 2. Of note, M CLL B cells produced higher basal levels of most of the soluble factors than did the UM CLL B cells. Co-culture of UM CLL B cells and autologous T cells resulted in a 4-fold increase in TNF-a secretion, a 5.5-fold increase in PDGF-BB secretion and a 2.9-fold increase in IL-8 secretion. By contrast, an increase in the concentration of these CKs was not observed in M B cell/T cell co-cultures (Figure 6c ). TNF-a, PDGF-BB and IL-8 are known to induce NF-kB activation. We, therefore, exposed UM CLL B cells to TNF-a, PDGF-BB and IL-8 for 3 and 7 days and analyzed nuclear extracts by EMSA at both time-points. The lowest dose used in the culture corresponded to the mean dose detected by Bio-Plex assay in the B cell/T cell co-culture supernatants. On day 3, a dose-dependent increase in NF-kB activity was detected. The positive effect exerted by TNF-a persisted for up to 7 days when this CK was used at the highest doses (Figure 6d ).
Discussion
This is the first study evaluating the tendency of purified M and UM CLL B cells to undergo spontaneous apoptosis in vitro and the role of prosurvival environmental signals. This is also the first study exploring the association of inducible NF-kB and Bcl-2 expression, with the mutational IGHV status.
CLL B cells from UM CLL patients showed significantly higher rates of in vitro apoptosis as compared with CLL B cells isolated from M patients. The progressive decline in UM CLL B cells viability was associated to a corresponding decline in cytoplasmic levels of Bcl-2. Bcl-2 and Bcl-2 family proteins are critical regulators of cell death and have been implicated in increased apoptosis described in CLL. 18 They are among the main transcriptional targets of nuclear active dimers of the transcriptional factor NF-kB. 23, 24 In vitro apoptosis of UM CLL B cells was associated to the total abrogation of NF-kB activity. NF-kB inactivation in UM CLL B cells was an early event occurring after just 1 day of culture and involved both RelA and RelB subunits, which are members of the canonical and alternative NF-kB pathways, respectively. 25 Engagement of BCR mainly leads to the activation of the canonical NF-kB pathway, which culminates in increased RelA DNA binding. In contrast, several BCR-independent environmental signals that is, CD40 L, LTab, BAFF (B cell-activating factor) and RANKL (receptor activator of NF-kB ligand)], activate the alternative NF-kB pathway, which results in an increase of RelB DNA binding. [26] [27] [28] [29] [30] Inter-patient variability in basal levels of RelA binding has been demonstrated in CLL, and found to correlate with in vitro CLL B cell survival as well as with clinical parameters of disease aggressiveness. 16 Similarly, variable expression of Bcl-2 family proteins has been demonstrated in CLL patients and was found to associate with differences in response to therapy and clinical outcome. 18 The observation that the low viability of UM CLL B cells was associated to a rapid inactivation of NF-kB and to a progressive decline of Bcl-2 expression, whereas the high viability of M CLL B cells was paralleled by the maintenance of both NF-kB and Bcl-2, further highlights the prosurvival role of these two molecules in CLL.
Spontaneous apoptosis of UM CLL B cells was reversed upon exposure to IL-4, CD40 L and stromal cells. The prosurvival effect of these signals was mediated by a positive regulation on Bcl-2 expression, but was totally independent from recovery of NF-kB activity. Despite being among the main transcriptional targets of NF-kB, Bcl-2 expression can be independent from the activation of NF-kB. Indeed, signaling pathways activated by the proximal region of IL-4 receptor were shown to induce Bcl-2 expression via a NF-kB independent mechanism. 31 Similarly, the prosurvival effect exerted by stromal cells on CLL B cells can be mediated by several NF-kB independent signaling pathways (i.e., CD31-CD38 signaling, 32 SDF1-CXCR4 signaling, 33 and hedgehog (Hh) signaling 34 ). Of note, CLL B cells did not undergo apoptosis when cultured within unfractionated PBMC. Differently from other environmental signals, PBMC exerted their prosurvival effect through a NF-kB dependent upregulation of Bcl-2. UM CLL B cells cultured for 7 days as purified B cells totally inactivated NF-kB. By contrast, UM CLL B cells cultured within PBMC maintained high levels of NF-kB expression. This observation suggests that UM PBMC contains a prosurvival cell component that activates NF-kB and up-regulates Bcl-2 in the leukemic cell fraction.
NLC are generated from the PBMC of CLL patients and provide NF-kB mediated prosurvival signals to CLL B cells through the interaction of BAFF and APRIL with the corresponding receptors. 35 Unexpectedly, we found that NLC were defectively generated from the PBMC of UM patients, whereas they were abundantly generated by the PBMC of M patients. This observation makes it clear that NLC play no role in the prosurvival effect exerted by PBMC on UM CLL B cells.
Our data indicate that T cells are a key prosurvival element within UM PBMC. One histological hallmark of CLL is the presence of focal aggregates of proliferating cells, called proliferation centers, which mainly consist of T cells.
12,36 CLL patients have a higher overall number of circulating T cells, oligoclonal in both the CD4 and the CD8 compartment, 37 which are reported to stimulate CLL B cell growth and survival. 38 The significantly shorter telomeres in T cells from high-risk CLL patients may indicate expansion in response to malignant cell growth, which to some extent contributes to the survival advantage of tumor cells. 39 It has already been reported that the course of CLL is influenced by the activation/differentiation status of T cells. 40 However, no data exist correlating the prosurvival effect of T cells with IGHV mutational status. Our results clearly demonstrate that the prosurvival effect of purified T cells on UM CLL B cells is mediated by restored translocation of NF-kB to the nucleus and partial recovery of Bcl-2 expression. The T-cell-mediated effect on NF-kB activity was dose-dependent and involved both canonical and alternative NF-kB signaling pathways.
It has been postulated that the T-cell-induced CD40 Lmediated activation of the NF-kB alternative pathway might regulate the expression and release of CK capable to activate canonical NF-kB signaling and RelA DNA binding. 27 In line with this assumption, we observed that the prosurvival effect exerted by T cells on UM CLL B cells was at least partially dependent upon soluble factors, as it was not abrogated in TW conditions. Moreover, it was associated to the positive regulation of NF-kB activity, both in cell-to-cell contact and in TW conditions. The observation of a more prominent prosurvival effect in conditions of cell-to-cell contact implies that soluble factors and surface molecules most likely cooperate in protecting UM CLL B cells from apoptosis.
CLL B cells induce changes in gene expression of CD4 and CD8T cells leading to the secretion of T cell CK, such as IL-4 and CD40 L, which in turn promote CLL cell survival. 41 To identify additional soluble factors involved in the NF-kB-mediated prosurvival effect of T cells, we analyzed the supernatants of B cell/T cell co-cultures for the secretion of 27 CK and CC. Data from these experiments showed that M CLL B cells produce higher levels of almost all of the CK and CC analyzed, suggesting that autocrine/paracrine loops may be responsible for the intrinsic resistance of these cells to apoptosis. Co-culture of UM CLL B cells and autologous T cells resulted in a marked increase in TNF-a, PDGF-BB and IL-8 secretion. These CK have already been described as CLL B cells survival factors [42] [43] [44] and are known to be inducers of NF-kB. 26, 45, 46 Consistent with these findings, we observed that stimulation of UM CLL B cells with increasing concentrations of these CK leads to a transient, dose-dependent activation of NF-kB nuclear translocation.
The results of this study show that the mechanisms of resistance to apoptosis relied on by UM CLL B cells do not depend exclusively on genetic or epigenetic features intrinsic to the tumor cell, but are driven by environmental signals received by the CLL B cells in vivo. UM CLL B cells are endowed with more competent BCR that activate a highly efficient transduction apparatus 47 that can be exploited by other environmental signals to activate common final targets, such as NF-kB and Bcl-2. Hewamana et al. reported that NF-kB inhibition is capable of overcoming the cytoprotective effect exerted by prosurvival signals, such as IL-4 and CD40 L, and is strongly active in poor prognostic subsets of CLL. 48 Targeting surface molecules or signaling pathways that are involved in crosstalk between malignant B cells and their microenvironment may therefore represent a promising strategy of therapeutic intervention, especially for UM CLL. In particular, a double therapeutic benefit may be provided by the inhibition of final targets, such as NF-kB and Bcl-2, which are activated by converging BCR-dependent and -independent signaling pathways.
